$0.8363
-0.0137-1.62%
Last update: Nov 11, 9:21 AM
XORTX Therapeutics Inc
XRTXNASDAQ
XORTX Therapeutics fell 71.0% from $2.94 to $0.85, behind the S&P 500's +9.8%. Its worst day was Oct 9 (−23.8%), and its low came Nov 9 at $0.85.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.65 beat the $-1.60 estimate on $0.00 revenue.
+1.5% · S&P 500 −0.8%
XORTX Therapeutics closed at its highest level of the year, 10.5% above where the year started.
Story events cover the past 12 months · Times ET
+2.8% · S&P 500 −0.3%
XORTX Therapeutics shares fell 17.7%, while the S&P 500 fell 1.2%.
−17.7% · S&P 500 −1.2%
EPS of $-0.45 beat the $-1.60 estimate on $0.00 revenue.
+1.5% · S&P 500 −0.5%
XORTX Therapeutics shares rose 29.5%, while the S&P 500 rose 2.5%.
+29.5%, the year's best day · S&P 500 +2.5%
EPS of $-0.58 was reported on $0.00 revenue.
+0.4% · S&P 500 −0.1%
EPS of $-1.05 was reported on $0.00 revenue.
+1.7% · S&P 500 −0.7%
XORTX Therapeutics shares rose 15.7%, while the S&P 500 rose 0.1%.
+15.7% · S&P 500 +0.1%
XORTX Therapeutics shares fell 23.8%, while the S&P 500 rose 0.6%.
−23.8%, the year's worst day · S&P 500 +0.6%
XORTX Therapeutics shares fell 18.5%, while the S&P 500 rose 0.4%.
−18.5% · S&P 500 +0.4%
Where it ended: a close of $0.85 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All XRTX analyst actionsNothing in the past 12 months.
All XRTX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for XRTX and SPY from Benzinga historical bars. Not investment advice.
